The Most Expensive Cities for Singles -- and the Cheapest
Looking for love in all the pricey places? Check out these lists of the most and least expensive cities for singles before you go on that next date or plan your next move. Looking good doesn’t come cheap, and the price of a decent wardrobe and a gym membership add ups before you even step out the door.
To determine which cities were the least and most affordable for singles, GoBankingRates examined 89 cities and rated them according to four expense categories -- clothing, dates, gym memberships and rent -- using data from Numbeo.com. “Singles are more likely to exercise, and to have a gym membership,” says Elyssa Kirkham, a finance writer for GoBankingRates. “They’re more likely to rent than own a home, and spend more money on dates and clothing.”
Related: Hot New Dating Criteria: What’s Your Credit Score?
San Francisco is the most expensive city for singles, especially when it comes to rent. Rent is 30 percent more expensive in San Francisco than it is in Honolulu. The cost of a date here is $147, compared with the median cost of $109. California just might be the most expensive state to date in, claiming seven of the top 15 spots: San Francisco, Fremont, Glendale, Irvine, Los Angeles, San Diego and Oakland.
The second most expensive city? New York City, which boasts the most expensive gym membership at $90 per month. Clothing costs here are the second-highest in the nation -- bad news for all the Carrie Bradshaws out there. And date night will set you back $145.
The most expensive date night in the country is in Washington, D.C., which came in third overall. Date night in our nation’s capital costs $166 for dinner, a bottle of wine, two movie tickets and a 10-mile taxi ride. Compare that to Chattanooga, Tennessee, which had the cheapest date night at $78.
Looking for more bang for your buck? Move to Reno, Nevada. Rent here is just 86 cents per square foot, and a night out averages $97.30. Keep in mind, though, that “the Biggest Little City in the World” was once known as the divorce capital of the world, so dating there may offer less promise than other locales.
Related: The Bad News About All the Singles in America
Most Expensive Cities for Singles
- San Francisco
- New York
- Washington, D.C.
- Honolulu
- Boston
- Fremont, California
- Glendale, California
- Anchorage, Alaska
- Miami
- Seattle
- Irvine, California
- Los Angeles
- San Diego
- Oakland, California
- Madison, Wisconsin
Related: Marriage?? Young Americans Aren’t Even Shacking Up
15 Cheapest Cities for Singles
- Reno, Nevada
- Tucson, Arizona
- Grand Rapids, Michigan
- Tacoma, Washington
- Indianapolis
- Mesa, Arizona
- Little Rock, Arkansas
- Albuquerque, New Mexico
- Huntsville, Alabama
- Memphis, Tennessee
- St. Louis, Missouri
- Jackson, Mississippi
- Stockton, California
- Omaha, Nebraska
- Chattanooga, Tennessee
Chart of the Day: High Deductible Blues
The higher the deductible in your health insurance plan, the less happy you probably are with it. That’s according to a new report on employer-sponsored health insurance from the Kaiser Family Foundation and the Los Angeles Times.
Chart of the Day: Tax Cuts and the Missing Capex Boom
Despite the Republican tax overhaul, businesses aren’t significantly increasing their capital expenditures. “The federal government will have to borrow an added $1 trillion through 2027 to pay for the corporate tax breaks,” says Bloomberg’s Mark Whitehouse. “So far, it’s hard to see what the country is getting in return.”
Chart of the Day: 2019’s Lobbying Leaders
Roll Call reports that trade, infrastructure and health care issues including prescription drug prices “dominated the lobbying agendas of some of the biggest spenders on K Street early this year.” Here’s Roll Call’s look at the top lobbying spenders so far this year:
Can You Fix Social Security? A New Tool Lets You Try
The Congressional Budget Office released an interactive tool Wednesday that shows how some widely discussed policy changes would affect the long-run financial health of the Social Security system.
“This interactive tool allows the user to explore seven policy options that could be used to improve the Social Security program’s finances and delay the trust funds’ exhaustion,” CBO said. “Four options would reduce benefits, and three options would increase payroll taxes. The tool allows for any combination of those options. It also lets the user change implementation dates and choose whether to show scheduled or payable benefits. … The tool also shows the impact of the options on different groups of people.”
Click here to view the interactive tool on the CBO website.
Why Prescription Drug Prices Keep Rising – and 3 Ways to Bring Them Down
Prescription drug prices have been rising at a blistering rate over the last few decades. Between 1980 and 2016, overall spending on prescription drugs rose from about $12 billion to roughly $330 billion, while its share of total health care spending doubled, from 5% to 10%.
Although lawmakers have shown renewed interest in addressing the problem, with pharmaceutical CEOs testifying before the Senate Finance Committee in February and pharmacy benefit managers (PBMS) scheduled to do so this week, no comprehensive plan to halt the relentless increase in prices has been proposed, let alone agreed upon.
Robin Feldman, a professor at the University of California Hastings College of Law, takes a look at the drug pricing system in a new book, “Drugs, Money and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices.” In a recent conversation with Bloomberg’s Joe Nocera, Feldman said that one of the key drivers of rising prices is the ongoing effort of pharmaceutical companies to maintain control of the market.
Fearing competition from lower-cost generics, drugmakers began over the last 10 or 15 years to focus on innovations “outside of the lab,” Feldman said. These innovations include paying PBMs to reduce competition from generics; creating complex systems of rebates to PBMs, hospitals and doctors to maintain high prices; and gaming the patent system to extend monopoly pricing power.
Feldman’s research on the dynamics of the drug market led her to formulate three general solutions for the problem of ever-rising prices:
1) Transparency: The current system thrives on secret deals between drug companies and middlemen. Transparency “lets competitors figure out how to compete and it lets regulators see where the bad behaviors occur,” Feldman says.
2) Patent limitations: Drugmakers have become experts at extending patents on existing drugs, often by making minor modifications in formulation, dosage or delivery. Feldman says that 78% of drugs getting new patents are actually old drugs gaining another round of protection, and thus another round of production and pricing exclusivity. A “one-and-done” patent system would eliminate this increasingly common strategy.
3) Simplification: Feldman says that “complexity breeds opportunity,” and warns that the U.S. “drug price system is so complex that the gaming opportunities are endless.” While “ruthless simplification” of regulatory rules and approval systems could help eliminate some of those opportunities, Feldman says that the U.S. doesn’t seem to be moving in this direction.
Read the full interview at Bloomberg News.